215 related articles for article (PubMed ID: 20514787)
21. Fractional photothermolysis treatment for resistant melasma in Chinese females.
Naito SK
J Cosmet Laser Ther; 2007 Sep; 9(3):161-3. PubMed ID: 17763024
[TBL] [Abstract][Full Text] [Related]
22. Successful treatment of acneiform scarring with CO2 ablative fractional resurfacing.
Chapas AM; Brightman L; Sukal S; Hale E; Daniel D; Bernstein LJ; Geronemus RG
Lasers Surg Med; 2008 Aug; 40(6):381-6. PubMed ID: 18649382
[TBL] [Abstract][Full Text] [Related]
23. Topical isotretinoin for melasma in Thai patients: a vehicle-controlled clinical trial.
Leenutaphong V; Nettakul A; Rattanasuwon P
J Med Assoc Thai; 1999 Sep; 82(9):868-75. PubMed ID: 10561942
[TBL] [Abstract][Full Text] [Related]
24. Combination of fractional erbium-glass laser and topical therapy in melasma resistant to triple-combination cream.
Tourlaki A; Galimberti MG; Pellacani G; Bencini PL
J Dermatolog Treat; 2014 Jun; 25(3):218-22. PubMed ID: 22385073
[TBL] [Abstract][Full Text] [Related]
25. Ablative fractional lasers (CO(2) and Er:YAG): a randomized controlled double-blind split-face trial of the treatment of peri-orbital rhytides.
Karsai S; Czarnecka A; Jünger M; Raulin C
Lasers Surg Med; 2010 Feb; 42(2):160-7. PubMed ID: 20166156
[TBL] [Abstract][Full Text] [Related]
26. Lower eyelid ablative fractional resurfacing: a new technique to treat skin laxity and photoaging.
Mezzana P; Scarinci F; Costantino A; Marabottini N; Valeriani M
Acta Chir Plast; 2010; 52(2-4):35-8. PubMed ID: 21749008
[TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy of topical metformin 30% cream versus triple combination cream (Kligman's formula) in treating melasma: A randomized controlled study.
AboAlsoud ES; Eldahshan RM; AbouKhodair Mohammed H; Elsaie ML
J Cosmet Dermatol; 2022 Jun; 21(6):2508-2515. PubMed ID: 35357753
[TBL] [Abstract][Full Text] [Related]
28. Long-term efficacy of a fractional resurfacing device.
Ortiz AE; Tremaine AM; Zachary CB
Lasers Surg Med; 2010 Feb; 42(2):168-70. PubMed ID: 20166157
[TBL] [Abstract][Full Text] [Related]
29. Comparative study of fractional Erbium: YAG laser vs combined therapy with topical steroid as an adjuvant treatment in melasma.
Abdel-Raouf Mohamed H; Ali Nasif G; Saad Abdel-Azim E; Abd El-Fatah Ahmed M
J Cosmet Dermatol; 2019 Apr; 18(2):517-523. PubMed ID: 30146730
[TBL] [Abstract][Full Text] [Related]
30. Ablative skin resurfacing with a novel microablative CO2 laser.
Gotkin RH; Sarnoff DS; Cannarozzo G; Sadick NS; Alexiades-Armenakas M
J Drugs Dermatol; 2009 Feb; 8(2):138-44. PubMed ID: 19213229
[TBL] [Abstract][Full Text] [Related]
31. Treatment of melasma with the 1,927-nm fractional thulium fiber laser: a retrospective analysis of 20 cases with long-term follow-up.
Niwa Massaki AB; Eimpunth S; Fabi SG; Guiha I; Groff W; Fitzpatrick R
Lasers Surg Med; 2013 Feb; 45(2):95-101. PubMed ID: 23255085
[TBL] [Abstract][Full Text] [Related]
32. Randomized controlled trial comparing the effectiveness of 308-nm excimer laser alone or in combination with topical hydrocortisone 17-butyrate cream in the treatment of vitiligo of the face and neck.
Sassi F; Cazzaniga S; Tessari G; Chatenoud L; Reseghetti A; Marchesi L; Girolomoni G; Naldi L
Br J Dermatol; 2008 Nov; 159(5):1186-91. PubMed ID: 18717675
[TBL] [Abstract][Full Text] [Related]
33. Ablative fractional CO2 resurfacing for photoaging of the hands: pilot study of 10 patients.
Stebbins WG; Hanke CW
Dermatol Ther; 2011; 24(1):62-70. PubMed ID: 21276159
[TBL] [Abstract][Full Text] [Related]
34. Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo.
Passeron T; Ostovari N; Zakaria W; Fontas E; Larrouy JC; Lacour JP; Ortonne JP
Arch Dermatol; 2004 Sep; 140(9):1065-9. PubMed ID: 15381545
[TBL] [Abstract][Full Text] [Related]
35. Nonablative 1550-nm fractional laser therapy versus triple topical therapy for the treatment of melasma: a randomized controlled pilot study.
Kroon MW; Wind BS; Beek JF; van der Veen JP; Nieuweboer-Krobotová L; Bos JD; Wolkerstorfer A
J Am Acad Dermatol; 2011 Mar; 64(3):516-23. PubMed ID: 21255869
[TBL] [Abstract][Full Text] [Related]
36. Treatment of melasma.
Rendon M; Berneburg M; Arellano I; Picardo M
J Am Acad Dermatol; 2006 May; 54(5 Suppl 2):S272-81. PubMed ID: 16631968
[TBL] [Abstract][Full Text] [Related]
37. Successful treatment of atrophic postoperative and traumatic scarring with carbon dioxide ablative fractional resurfacing: quantitative volumetric scar improvement.
Weiss ET; Chapas A; Brightman L; Hunzeker C; Hale EK; Karen JK; Bernstein L; Geronemus RG
Arch Dermatol; 2010 Feb; 146(2):133-40. PubMed ID: 20157023
[TBL] [Abstract][Full Text] [Related]
38. Treatment of melasma using a novel 1,927-nm fractional thulium fiber laser: a pilot study.
Polder KD; Bruce S
Dermatol Surg; 2012 Feb; 38(2):199-206. PubMed ID: 22093448
[TBL] [Abstract][Full Text] [Related]
39. Botulinum toxin type A enhances the outcome of fractional resurfacing of the cheek.
Beer K; Waibel J
J Drugs Dermatol; 2007 Nov; 6(11):1151-2. PubMed ID: 18038503
[TBL] [Abstract][Full Text] [Related]
40. The efficacy in treatment of facial melasma with thulium 1927-nm fractional laser-assisted topical tranexamic acid delivery: a split-face, double-blind, randomized controlled pilot study.
Wanitphakdeedecha R; Sy-Alvarado F; Patthamalai P; Techapichetvanich T; Eimpunth S; Manuskiatti W
Lasers Med Sci; 2020 Dec; 35(9):2015-2021. PubMed ID: 32506227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
